Evaluation of Rifaximin SSD for Delaying Encephalopathy Decompensation in Patients With Cirrhosis
Running, not enrolling · Phase 3 · Has a placebo group
Conditions studied: Hepatic Encephalopathy
In brief
Study RNLC3132 is a Phase 3, randomized, double-blind, placebo-controlled, multicenter study to assess the efficacy and safety of rifaximin SSD-40mg IR for the delay of the first episode of overt hepatic encephalopathy (OHE) decompensation in liver cirrhosis, defined by the presence of medically controlled ascites.
Key facts
- Study ID
- NCT05297448
- Run by
- Bausch Health Americas, Inc.
- People needed
- 466
- Starts
- 2022-08-03
- Expected to finish
- 2026-01-01
- Last updated by the study team
- 2025-09-10
Who can join
Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Bausch Site 969 — Sliven, Bulgaria
- Bausch Site 591 — Homewood, Alabama, United States
- Bausch Site 445 — Chandler, Arizona, United States
- Bausch Site 453 — Sun City, Arizona, United States
- Bausch Site 587 — Tucson, Arizona, United States
- Bausch Site 550 — Bakersfield, California, United States
- Bausch Site 415 — Coronado, California, United States
- Bausch Site 585 — Covina, California, United States
- Bausch Site 585 — Covina, California, United States
- Bausch Site 592 — Fresno, California, United States
- Bausch Site 582 — Lancaster, California, United States
- Bausch Site 590 — Long Beach, California, United States
- Bausch Site 414 — Los Angeles, California, United States
- Bausch Site 405 — Orange, California, United States
- Bausch Site 482 — Valencia, California, United States
- Bausch Site 575 — Colorado Springs, Colorado, United States
- Bausch Site 425 — Doral, Florida, United States
- Bausch Site 449 — Hialeah, Florida, United States
- Bausch Site 558 — Hialeah, Florida, United States
- Bausch Site 418 — Hialeah, Florida, United States
- Bausch Site 468 — Hollywood, Florida, United States
- Bausch Site 495 — Miami, Florida, United States
- Bausch Site 543 — Miami, Florida, United States
- Bausch Site 479 — Miami, Florida, United States
- Bausch Site 982 — Rousse, Bulgaria
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.